NCCM
ACHV icon

Nine Chapters Capital Management’s Achieve Life Sciences ACHV Stock Holding History

Nine Chapters Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-17
Closed -$17K – 59
2017
Q1 		$17K Buy
17
+9
+113% +$10.9K 0.02% 233
2016
Q4 		$9K Buy
+8
New +$7.9K 0.02% 170
2015
Q3 		– Sell
-32
Closed -$165K – 976
2015
Q2 		$165K Sell
32
-12
-27% -$59.5K 0.01% 825
2015
Q1 		$207K Sell
44
-8
-15% -$39.3K 0.02% 819
2014
Q4 		$260K Buy
+52
New +$254K 0.02% 718

Other funds holding ACHV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nine Chapters Capital Management's ACHV Position: Q2 2017 in Review

Nine Chapters Capital Management sold out of Achieve Life Sciences (ACHV) in Q2 2017, closing a stake of 17 shares — an estimated $17K sold.

Nine Chapters Capital Management first reported a position in ACHV in Q4 2014 and held it in 5 quarters. The position peaked at $260K in Q4 2014. 25 funds tracked by Wall St. Rank hold ACHV as of Q2 2017.

  • Nine Chapters Capital Management reported no remaining Achieve Life Sciences position as of Q2 2017 after selling out during the quarter.
  • Nine Chapters Capital Management sold 17 Achieve Life Sciences shares in Q2 2017, an estimated $17K.
  • Nine Chapters Capital Management first reported a position in Achieve Life Sciences in Q4 2014 and held it in 5 quarters.
  • Nine Chapters Capital Management's Achieve Life Sciences position peaked at $260K in Q4 2014.
  • 25 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2017.

Based on Nine Chapters Capital Management's 13F filing for Q2 2017, filed 31 Jul 2017.